BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38291214)

  • 1. The impact of divergent forms of social support on health-related quality of life in patients with multiple myeloma and its precursor states.
    Greinacher A; Kuehl R; Mai EK; Goldschmidt H; Wiskemann J; Fleischer A; Rasche L; Dapunt U; Maatouk I
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):55. PubMed ID: 38291214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires.
    Ficko SL; Pejsa V; Zadnik V
    Radiol Oncol; 2019 Sep; 53(3):337-347. PubMed ID: 31553711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Quality of Life Multiple Myeloma Module Questionnaire (QLQ-MY20) in Portuguese myeloma patients.
    Graça Pereira M; Ferreira G; Pereira M; Faria S; Bacalhau R; Monteiro S; Fernandes B; Vilaça M
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13128. PubMed ID: 31273859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.
    Ramsenthaler C; Osborne TR; Gao W; Siegert RJ; Edmonds PM; Schey SA; Higginson IJ
    BMC Cancer; 2016 Jul; 16():427. PubMed ID: 27387201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study.
    Fischer J; Knop S; Danhof S; Einsele H; Keller D; Löffler C
    BMC Cancer; 2022 Oct; 22(1):1032. PubMed ID: 36192719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development.
    Forde K; Cocks K; Wells JR; McMillan I; Kyriakou C;
    Blood Cancer J; 2023 May; 13(1):79. PubMed ID: 37193682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
    Kiely F; Cran A; Finnerty D; O'Brien T
    Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity and health-related quality of life in multiple myeloma survivors: the PROFILES registry.
    Servadio M; Cottone F; Sommer K; Oerlemans S; van de Poll-Franse L; Efficace F
    BMJ Support Palliat Care; 2020 Dec; 10(4):e35. PubMed ID: 31253733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
    Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
    Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma.
    de Lima MSR; de Pádua CAM; de Miranda Drummond PL; Silveira LP; Malta JS; Dos Santos RMM; Reis AMM
    Support Care Cancer; 2023 Jun; 31(7):379. PubMed ID: 37278732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France.
    Despiégel N; Touboul C; Flinois A; Saba G; Suzan F; Gonzalez-McQuire S; Bonnetain F
    Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e13-e28. PubMed ID: 30292736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients.
    Sully K; Trigg A; Bonner N; Moreno-Koehler A; Trennery C; Shah N; Yucel E; Panjabi S; Cocks K
    Eur J Haematol; 2019 Nov; 103(5):500-509. PubMed ID: 31444815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma.
    Balderas-Peña LM; Miranda-Ruvalcaba C; Robles-Espinoza AI; Sat-Muñoz D; Ruiz MG; García-Luna E; Nava-Zavala AH; Rubio-Jurado B
    Cancer Control; 2019; 26(1):1073274819831281. PubMed ID: 30786721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer.
    Gonzalez-Saenz de Tejada M; Bilbao A; Baré M; Briones E; Sarasqueta C; Quintana JM; Escobar A
    Psychooncology; 2016 Aug; 25(8):891-7. PubMed ID: 26582649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
    Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
    Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma.
    Malta JS; Silveira LP; Drummond PLM; Costa NL; Dos Santos RMM; Reis IA; Reis AMM; de Pádua CAM
    Curr Med Res Opin; 2021 Jul; 37(7):1163-1169. PubMed ID: 33979261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study.
    Dachs LR; Gaisán CM; Bustamante G; López SG; García EG; Persona EP; González-Calle V; Auzmendi MS; Pérez JMA; González Montes Y; Ríos Tamayo R; de Miguel Llorente D; Bernal LP; Mayol AS; Caro CC; Grande M; Fernández-Nistal A; Naves A; Miguel EMOS
    Leuk Lymphoma; 2023; 64(11):1847-1856. PubMed ID: 37539698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
    Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
    Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of physical function in patients with multiple myeloma for improving quality of life.
    Kim SH; Kim I; Koh Y; Shin D; Hong J; Seo KS
    Support Care Cancer; 2020 May; 28(5):2361-2367. PubMed ID: 31486982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.